MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

Simbionix Launches Innovative Patient-Specific Simulation

— CLEVELAND, Ohio, October 3

CLEVELAND, Ohio, October 3 /PRNewswire/ -- Simbionix, the world's leading developer of medical simulation systems, advances procedural simulation from theoretical promise to operating room reality.

The PROcedure Rehearsal Studio(TM), Simbionix' latest innovative medical simulation system, is the world's first medical simulator that enables clinicians to create practice scenarios based on their patient's unique pathology and anatomy.

Dr. Karl Illig, Chief of Vascular Surgery at Strong Medical Center in Rochester, NY, explains why physicians are eager to start using the new simulator: "PROcedure Studio helps us identify pitfalls and problems and solve them on the machine. If we're going to make a mistake, let's make it on the simulators first."

Gary Zamler, CEO of Simbionix, sees the launch of Procedure as "a quantum leap in the world of medical simulation that has the potential to significantly improve patient outcomes while reducing health care costs."

"Our leading technology has made Simbionix the industry leader in medical simulation. PROcedure Rehearsal Studio shows where that leadership will be taking everyone."

Mr. Zamler also announced that Strong Medical Center in Rochester, NY, Imperial College, UK, and Sheba Hospital, Israel have already signed agreements with Simbionix to use PROcedure Rehearsal Studio in their simulation centers.

"These leading hospitals will use and test PROcedure Rehearsal Studio in accordance with Simbionix' philosophy and mission to collaborate with the medical community developing leading-edge technologies for training and education while promoting patient safety."

Simbionix will unveil this next generation of medical simulation on October 12th at the Annual Transcatheter Cardiovascular Therapeutic symposium (TCT) in Washington, DC.

Company Description

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures.

http://www.simbionix.com

Contact: Inbal Mazor VP Marketing Simbionix inbal@simbionix.com Tel: +972-8-9211177

Related news

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
The countdown has started...
Stem Cell USA
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us